Gerresheimer invests in Portal’s needle-free drug delivery

Jun 14, 2022

handshake

Gerresheimer has signed up to support development of Portal Instruments’ needle-free drug delivery platform, taking a stake in its new partner and agreeing to throw its weight behind a technology that has attracted the attention of Takeda.

Source: Gerresheimer invests in Portal’s needle-free drug delivery | Fierce Pharma

Hire with SEC


Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.

"*" indicates required fields

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Pin It on Pinterest